Ajanta Pharma Limited (NSE:AJANTPHARM) — Market Cap & Net Worth

$4.15 Billion USD · Rs384.00 Billion INR · Rank #4098

Market Cap & Net Worth: Ajanta Pharma Limited (AJANTPHARM)

Ajanta Pharma Limited (NSE:AJANTPHARM) has a market capitalization of $4.15 Billion (Rs384.00 Billion) as of June 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #4098 globally and #171 in its home market, demonstrating a -0.04% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ajanta Pharma Limited's stock price Rs3073.60 by its total outstanding shares 124935624 (124.94 Million). Review debt load of Ajanta Pharma Limited to assess the company's total debt and financial obligations.

Ajanta Pharma Limited Market Cap History: 2015 to 2026

Ajanta Pharma Limited's market capitalization history from 2015 to 2026. Data shows growth from $1.11 Billion to $4.15 Billion (11.45% CAGR).

Index Memberships

Ajanta Pharma Limited is a constituent of 5 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY PHARMA CNXPHARMA	$92.18 Billion	4.51%	#9 of 20
NIFTY 500 NIFTY500	$3.15 Trillion	0.13%	#158 of 500
NIFTY MIDCAP 150 NIFTYMIDCAP150	$719.90 Billion	0.58%	#74 of 150
NIFTY MIDSMALLCAP 400 NIFTYMIDSML400	$1.15 Trillion	0.36%	#84 of 400
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.24 Trillion	0.13%	#156 of 750

Weight: Ajanta Pharma Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Ajanta Pharma Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Ajanta Pharma Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.08x

Ajanta Pharma Limited's market cap is 0.08 times its annual revenue

Industry average: 0.53x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.41x

Ajanta Pharma Limited's market cap is 0.41 times its annual earnings

Industry average: 0.02x Higher than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$1.50 Billion	$17.08 Billion	$4.01 Billion	0.09x	0.37x
2017	$1.26 Billion	$19.16 Billion	$5.07 Billion	0.07x	0.25x
2018	$1.01 Billion	$20.60 Billion	$4.69 Billion	0.05x	0.21x
2019	$838.73 Million	$20.16 Billion	$3.87 Billion	0.04x	0.22x
2020	$1.41 Billion	$25.62 Billion	$4.68 Billion	0.06x	0.30x
2021	$1.94 Billion	$28.47 Billion	$6.54 Billion	0.07x	0.30x
2022	$1.59 Billion	$32.84 Billion	$7.13 Billion	0.05x	0.22x
2023	$2.76 Billion	$37.43 Billion	$5.88 Billion	0.07x	0.47x
2024	$3.96 Billion	$42.09 Billion	$8.16 Billion	0.09x	0.49x
2025	$3.74 Billion	$46.48 Billion	$9.20 Billion	0.08x	0.41x

Competitor Companies of AJANTPHARM by Market Capitalization

Companies near Ajanta Pharma Limited in the global market cap rankings as of June 19, 2026.

Key companies related to Ajanta Pharma Limited by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #555 globally with a market cap of $48.78 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #601 globally with a market cap of $45.20 Billion USD ( CN¥308.87 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #627 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#515	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#555	GALDERMA GROUP AG	NYSE:GALDY	$48.78 Billion	$42.94
#601	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$45.20 Billion	CN¥48.42
#627	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€13.30

Ajanta Pharma Limited Historical Marketcap From 2015 to 2026

Between 2015 and today, Ajanta Pharma Limited's market cap moved from $1.11 Billion to $ 4.15 Billion, with a yearly change of 11.45%.

Year	Market Cap	Change (%)
2026	Rs4.15 Billion	+11.00%
2025	Rs3.74 Billion	-5.57%
2024	Rs3.96 Billion	+43.66%
2023	Rs2.76 Billion	+73.44%
2022	Rs1.59 Billion	-18.22%
2021	Rs1.94 Billion	+37.48%
2020	Rs1.41 Billion	+68.63%
2019	Rs838.73 Million	-16.70%
2018	Rs1.01 Billion	-19.83%
2017	Rs1.26 Billion	-16.02%
2016	Rs1.50 Billion	+35.08%
2015	Rs1.11 Billion	--

End of Day Market Cap According to Different Sources

On Jun 19th, 2026 the market cap of Ajanta Pharma Limited was reported to be:

Source	Market Cap
Yahoo Finance	$4.15 Billion USD
MoneyControl	$4.15 Billion USD
MarketWatch	$4.15 Billion USD
marketcap.company	$4.15 Billion USD
Reuters	$4.15 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Ajanta Pharma Limited

NSE:AJANTPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$4.15 Billion

Rs384.00 Billion INR

Market Cap Rank

#4098 Global

#171 in India

Share Price

Rs3073.60

Change (1 day)

-0.19%

52-Week Range

Rs2388.40 - Rs3259.20

All Time High

Rs3395.67